Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer.

Curr Oncol · 2021 · PMC8025826 · PMID 33804070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with low level of expression of miR-618 in serum showed a trend towards shorter mean PFS of 6.15 months (95% CI: 4.41–7.88) as compared to those with high/intermediate expression of miR-618—7.84 months (95%, CI: 6.80–8.86) (log-rank test, p = 0.061, data not shown). 3.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.